1. Home
  2. SPCB vs GLMD Comparison

SPCB vs GLMD Comparison

Compare SPCB & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • GLMD
  • Stock Information
  • Founded
  • SPCB 1988
  • GLMD 2000
  • Country
  • SPCB Israel
  • GLMD Israel
  • Employees
  • SPCB N/A
  • GLMD N/A
  • Industry
  • SPCB Semiconductors
  • GLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • GLMD Health Care
  • Exchange
  • SPCB Nasdaq
  • GLMD Nasdaq
  • Market Cap
  • SPCB 6.3M
  • GLMD 5.9M
  • IPO Year
  • SPCB N/A
  • GLMD 2014
  • Fundamental
  • Price
  • SPCB $3.56
  • GLMD $2.93
  • Analyst Decision
  • SPCB
  • GLMD
  • Analyst Count
  • SPCB 0
  • GLMD 0
  • Target Price
  • SPCB N/A
  • GLMD N/A
  • AVG Volume (30 Days)
  • SPCB 75.1K
  • GLMD 97.1K
  • Earning Date
  • SPCB 11-14-2024
  • GLMD 11-22-2024
  • Dividend Yield
  • SPCB N/A
  • GLMD N/A
  • EPS Growth
  • SPCB N/A
  • GLMD N/A
  • EPS
  • SPCB 1.02
  • GLMD N/A
  • Revenue
  • SPCB $26,843,000.00
  • GLMD N/A
  • Revenue This Year
  • SPCB $6.34
  • GLMD N/A
  • Revenue Next Year
  • SPCB $16.25
  • GLMD N/A
  • P/E Ratio
  • SPCB $3.53
  • GLMD N/A
  • Revenue Growth
  • SPCB 5.23
  • GLMD N/A
  • 52 Week Low
  • SPCB $2.55
  • GLMD $2.73
  • 52 Week High
  • SPCB $11.00
  • GLMD $23.80
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 50.84
  • GLMD 39.04
  • Support Level
  • SPCB $3.26
  • GLMD $2.73
  • Resistance Level
  • SPCB $4.00
  • GLMD $3.13
  • Average True Range (ATR)
  • SPCB 0.24
  • GLMD 0.30
  • MACD
  • SPCB 0.04
  • GLMD 0.02
  • Stochastic Oscillator
  • SPCB 49.74
  • GLMD 16.53

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Share on Social Networks: